Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Meeting Confirms Urgent Need for Rapid Testing
Tweet
Share
E-mailGet Alerts OSUR Hot Sheet
Price: $3.88 +3.74%
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $14.00.
Analyst, Jeffrey Frelick, said, "We reiterate our rating on OSUR following a recent meeting with a large community health clinic, which confirmed the critical importance of rapid point-of-care testing for HIV / HCV."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $11.39 yesterday.
Analyst, Jeffrey Frelick, said, "We reiterate our rating on OSUR following a recent meeting with a large community health clinic, which confirmed the critical importance of rapid point-of-care testing for HIV / HCV."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $11.39 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Revolution (RVMD) PT Raised to $179 at Bernstein SocGen Group
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
